Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · IEX Real-Time Price · USD
18.64
-0.19 (-1.01%)
At close: Jul 19, 2024, 4:00 PM
18.58
-0.06 (-0.32%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Phibro Animal Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for PAHC stock have an average target of 16.67, with a low estimate of 13 and a high estimate of 21. The average target predicts a decrease of -10.57% from the current stock price of 18.64.
Analyst Consensus: Hold
* Price targets were last updated on May 10, 2024.
Analyst Ratings
The average analyst rating for PAHC stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains $10 → $13 | Sell | Maintains | $10 → $13 | -30.26% | May 10, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $16 | Hold | Maintains | $17 → $16 | -14.16% | Nov 9, 2023 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +12.66% | Sep 1, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | -8.80% | Aug 31, 2023 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +12.66% | Aug 29, 2023 |
Financial Forecast
Revenue This Year
1.03B
from 977.89M
Increased by 5.12%
Revenue Next Year
1.20B
from 1.03B
Increased by 16.63%
EPS This Year
1.15
from 0.81
Increased by 42.30%
EPS Next Year
1.50
from 1.15
Increased by 30.38%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.1B | 1.5B | 1.6B | 1.2B | 1.2B | 1.2B |
| Avg | 1.0B | 1.2B | 1.3B | 1.1B | 1.2B | 1.2B |
| Low | 984.9M | 1.0B | 1.0B | 1.1B | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 8.6% | 47.2% | 30.0% | -11.5% | 6.4% | 5.3% |
| Avg | 5.1% | 16.6% | 8.4% | -14.0% | 3.3% | 2.3% |
| Low | 0.7% | -1.2% | -13.0% | -17.4% | -0.8% | -1.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.20 | 1.90 | 2.03 | 1.65 |
| Avg | 1.15 | 1.50 | 1.76 | 1.60 |
| Low | 1.10 | 1.20 | 1.50 | 1.54 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 47.8% | 64.9% | 34.8% | -6.6% |
| Avg | 42.3% | 30.4% | 17.4% | -9.2% |
| Low | 35.5% | 3.7% | -0.2% | -12.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.